Fundz

Cytovale Receives Additional BARDA Funding to Evaluate Rapid Sepsis Diagnostic in Persons Under Investigation (PUI) for COVID-19

PRIVATEApr 23, 2020

Round Type

Funding Round

San FranciscoOtherBiotechnology

Description

Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, announced today the expansion of a partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to conduct a pilot study for Cytovale’s Rapid Sepsis Diagnostic System for patients with potential respiratory infections, including those with SARS-CoV-2, responsible for COVID-19.

Quick answer

Cytovale raised an undisclosed amount in a Funding Round round, dated April 23, 2020. Cytovale is based in San Francisco, California, United States.

How much did Cytovale raise?
Cytovale raised an undisclosed amount in a Funding Round round on April 23, 2020.
What does Cytovale do?
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases.
Where is Cytovale based and how big is it?
Cytovale is based in San Francisco, California, United States. Fundz records about 120 employees.
Who are the decision-makers at Cytovale?
Fundz holds 1 contact at Cytovale. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Cytovale that raised within 45 days of this round, from Fundz verified event records.

  • Lisata Therapeutics raised $2.2M (Seed) on June 5, 2020.
  • CereVasc raised $11M on June 5, 2020.
  • Kineta, Inc. raised $100K (Seed) on June 4, 2020.
  • Laxmi Therapeutic Devices raised $3.6M (Seed) on June 4, 2020.
  • Statera Biopharma raised $1.6M (Seed) on June 4, 2020.
  • Milagen, Inc. raised $3.3M (Seed) on June 3, 2020.

Who to call at Cytovale, and when

A new round usually means Cytovale is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cytovale raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cytovale, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cytovale. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cytovale

Location

150 EXECUTIVE PARK BLVD, SUITE 4100

San Francisco, California, United States

About

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cytovale raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts14 people are listed at Cytovale. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cytovale's next move

See what Strategic adds

Cytovale raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.